ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $221,092 | -58.9% | 6,200 | -70.8% | 0.00% | -87.5% |
| Q1 2023 | $538,480 | +63.9% | 21,200 | +161.7% | 0.01% | +33.3% |
| Q4 2022 | $328,536 | +50.0% | 8,100 | +30.4% | 0.01% | 0.0% |
| Q2 2022 | $219,000 | -79.8% | 6,213 | -73.6% | 0.01% | -79.3% |
| Q1 2022 | $1,083,000 | +310.2% | 23,543 | +491.5% | 0.03% | +93.3% |
| Q1 2021 | $264,000 | -82.5% | 3,980 | -83.3% | 0.02% | -84.7% |
| Q4 2019 | $1,509,000 | +110.8% | 23,800 | -6.3% | 0.10% | +127.9% |
| Q3 2019 | $716,000 | +244.2% | 25,400 | +124.8% | 0.04% | +22.9% |
| Q1 2019 | $208,000 | +14.9% | 11,300 | +20.0% | 0.04% | -58.3% |
| Q3 2018 | $181,000 | – | 9,416 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |